UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

Journal of thrombosis and haemostasis, 2008-04, Vol.6 (4), p.632-637

2008

Volltextzugriff (PDF)

Current perspective of venous thrombosis in the upper extremity

Journal of thrombosis and haemostasis, 2008-08, Vol.6 (8), p.1262-1266

2008

Volltextzugriff (PDF)

High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.839-846

2014

Volltextzugriff (PDF)

Mechanisms of the factor V Leiden paradox

Arteriosclerosis, thrombosis, and vascular biology, 2008-10, Vol.28 (10), p.1872-1877

2008

Volltextzugriff (PDF)

Old and new risk factors for upper extremity deep venous thrombosis

Journal of thrombosis and haemostasis, 2005-11, Vol.3 (11), p.2471-2478

2005

Volltextzugriff (PDF)

Recurrent Thrombosis and Survival After a First Venous Thrombosis of the Upper Extremity

Circulation (New York, N.Y.), 2008-09, Vol.118 (13), p.1366-1372

2008

Volltextzugriff (PDF)

Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis

Human reproduction (Oxford), 2005-03, Vol.20 (3), p.802-806

2005

Volltextzugriff (PDF)

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer

Annals of oncology, 2010-09, Vol.21 (9), p.1851-1857

2010

Volltextzugriff (PDF)

Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis

Journal of thrombosis and haemostasis, 2008-12, Vol.6 (12), p.2075-2081

2008

Volltextzugriff (PDF)

Predicting whether patients in an acute medical unit are physiologically fit-for-discharge using machine learning: A proof-of-concept

International journal of medical informatics (Shannon, Ireland), 2024-11, Vol.191, p.105586, Article 105586

2024

Volltextzugriff (PDF)

Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis

Journal of thrombosis and haemostasis, 2008-09, Vol.6 (9), p.1474-1477

2008

Volltextzugriff (PDF)

HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis

Journal of thrombosis and haemostasis, 2009-04, Vol.7 (4), p.514-520

2009

Volltextzugriff (PDF)

Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Diabetic patients treated with novel thin composite-wire strut zotarolimus-eluting stents versus ultrathin strut sirolimus-eluting stents in the BIONYX trial: 2-year results of a prespecified analysis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Venous thrombosis in the elderly

Journal of thrombosis and haemostasis, 2007-07, Vol.5 (s1), p.310-317

2007

Volltextzugriff (PDF)

Incidence and prognostic factors of chronic pain after isolated musculoskeletal extremity injury

European journal of pain, 2016-05, Vol.20 (5), p.711-722

2016

Volltextzugriff (PDF)

Predictors of the post‐thrombotic syndrome with non‐invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2685-2692

2010

Volltextzugriff (PDF)

2925Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: insights from the DUTCH PEERS trial

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Regular sports activities decrease the risk of venous thrombosis

Journal of thrombosis and haemostasis, 2007-11, Vol.5 (11), p.2186-2192

2007

Volltextzugriff (PDF)

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women

Journal of thrombosis and haemostasis, 2004-05, Vol.2 (5), p.700-701

2004

Volltextzugriff (PDF)

The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population‐based case–control study

Journal of thrombosis and haemostasis, 2006-12, Vol.4 (12), p.2587-2592

2006

Volltextzugriff (PDF)

Regionale traumaregistratie: de in- en exclusie van patiënten in de praktijk

Nederlands tijdschrift voor traumachirurgie, 2016-04, Vol.24 (2), p.2-7

2016

Volltextzugriff (PDF)

Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction

Journal of thrombosis and haemostasis, 2008-05, Vol.6 (5), p.720-725

2008

Volltextzugriff (PDF)

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

Journal of vascular surgery, 2006-04, Vol.43 (4), p.866-866

2006

Volltextzugriff (PDF)

Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels

Journal of thrombosis and haemostasis, 2010-07, Vol.8 (7), p.1547-1554

2010

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study

Current perspective of venous thrombosis in the upper extremity

High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study

Mechanisms of the factor V Leiden paradox

Old and new risk factors for upper extremity deep venous thrombosis

Recurrent Thrombosis and Survival After a First Venous Thrombosis of the Upper Extremity

Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer

Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis

Predicting whether patients in an acute medical unit are physiologically fit-for-discharge using machine learning: A proof-of-concept

Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis

HMG‐CoA reductase inhibitors, other lipid‐lowering medication, antiplatelet therapy, and the risk of venous thrombosis

Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials

Diabetic patients treated with novel thin composite-wire strut zotarolimus-eluting stents versus ultrathin strut sirolimus-eluting stents in the BIONYX trial: 2-year results of a prespecified analysis

Venous thrombosis in the elderly

Incidence and prognostic factors of chronic pain after isolated musculoskeletal extremity injury

Predictors of the post‐thrombotic syndrome with non‐invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis

2925Four-year clinical outcome following randomised use of zotarolimus-eluting stents versus everolimus-eluting stents in all-comers: insights from the DUTCH PEERS trial

Regular sports activities decrease the risk of venous thrombosis

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women

The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population‐based case–control study

Regionale traumaregistratie: de in- en exclusie van patiënten in de praktijk

Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels

Suchergebnisse filtern